Hernández-Pedro, N.; Arroyo-Hernández, M.; Barrios-Bernal, P.; Romero-Nuñez, E.; Sosa-Hernandez, V.A.; Ávila-Ríos, S.; Maravillas-Montero, J.L.; Pérez-Padilla, R.; de Miguel-Perez, D.; Rolfo, C.;
et al. Correction: Hernández-Pedro et al. Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Thoracic Malignancies. Vaccines 2023, 11, 1612. Vaccines 2025, 13, 913.
https://doi.org/10.3390/vaccines13090913
AMA Style
Hernández-Pedro N, Arroyo-Hernández M, Barrios-Bernal P, Romero-Nuñez E, Sosa-Hernandez VA, Ávila-Ríos S, Maravillas-Montero JL, Pérez-Padilla R, de Miguel-Perez D, Rolfo C,
et al. Correction: Hernández-Pedro et al. Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Thoracic Malignancies. Vaccines 2023, 11, 1612. Vaccines. 2025; 13(9):913.
https://doi.org/10.3390/vaccines13090913
Chicago/Turabian Style
Hernández-Pedro, Norma, Marisol Arroyo-Hernández, Pedro Barrios-Bernal, Eunice Romero-Nuñez, Victor A. Sosa-Hernandez, Santiago Ávila-Ríos, José Luis Maravillas-Montero, Rogelio Pérez-Padilla, Diego de Miguel-Perez, Christian Rolfo,
and et al. 2025. "Correction: Hernández-Pedro et al. Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Thoracic Malignancies. Vaccines 2023, 11, 1612" Vaccines 13, no. 9: 913.
https://doi.org/10.3390/vaccines13090913
APA Style
Hernández-Pedro, N., Arroyo-Hernández, M., Barrios-Bernal, P., Romero-Nuñez, E., Sosa-Hernandez, V. A., Ávila-Ríos, S., Maravillas-Montero, J. L., Pérez-Padilla, R., de Miguel-Perez, D., Rolfo, C., & Arrieta, O.
(2025). Correction: Hernández-Pedro et al. Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Thoracic Malignancies. Vaccines 2023, 11, 1612. Vaccines, 13(9), 913.
https://doi.org/10.3390/vaccines13090913
